Peering Into Horizon Therapeutics's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Horizon Therapeutics's (NYSE:HZNP) short percent of float has fallen 7.73% since its last report, with 7.86 million shares sold short, which is 3.46% of all regular shares available for trading. It would take traders 5.02 days to cover their short positions on average. The company has less short interest than most of its peers, with the peer group average for short interest as a percentage of float being 3.71%.
August 31, 2023 | 4:15 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Horizon Therapeutics's short percent of float has decreased, indicating a potentially more bullish sentiment towards the stock. However, this does not necessarily mean the stock price will rise in the near term.
A decrease in short interest can signal that investors have become more bullish towards a stock. However, this is not a definitive indicator of a stock price increase, as other market factors also play a role. Horizon Therapeutics has less short interest than most of its peers, which could be seen as a positive sign, but it's important to consider the overall market context.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100